Travere Therapeutic TVTX 深 沪
等待开盘 10-14 09:30:00 美东时间
51.80
-0.220
-0.42%
华盛通- 最 高52.81
- 今 开51.57
- 成交量 166.86万股
- 最 低 51.38
- 昨 收 52.02
- 总市值 48.83亿
- 52周最高 68.73
- 市盈率 静 --
- 换手率 1.77%
- 52周最低 22.59
- 委 比 55.86%
- 总股本 9426.11万
- 历史最高 68.73
- 量 比 0.77
- 振 幅 2.75%
- 历史最低 0.90
- 每 手 1
- 风险率 13.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | Meta获4家机构齐升目标价，最高看至995美元！麦当劳遭6家机构下调，最低看至260美元
今日重点评级关注：Canaccord Genuity：维持Aurora Innovation"买入"评级，目标价从15美元升至17美元；摩根大通：维持皇家加勒比邮轮"超配"评级，目标价从345美元升至394美元
09-25 15:55
美股大行评级 | Muse热度发酵，Meta目标价获大幅升至875美元；闪迪获看好至2400美元，潜在升幅约27%
今日重点评级关注：Citizens：上调Quince Therapeutics评级至"跑赢大市"，目标价77美元；康托·菲茨杰拉德：维持塞德斯医疗"超配"评级，目标价从61美元升至72美元
09-23 15:30
Wedbush Reiterates Outperform on Travere Therapeutics, Maintains $76 Price Target
Wedbush analyst Laura Chico reiterates Travere Therapeutics (NASDAQ:TVTX) with a Outperform and maintains $76 price target.
09-22 20:38
Travere Therapeutics appoints new CEO Bradley Campbell
Travere Therapeutics ( ($TVTX) ) has issued an announcement. On September 21, 2...
09-22 04:55
Travere Therapeutics Appoints Bradley L. Campbell President, CEO, Effective Dec. 1, Succeeding Eric Dube
Travere Therapeutics, Inc. (NASDAQ:TVTX) today announced that Eric Dube, Ph.D., has made the difficult and personal decision to step down as president and chief executive officer to focus on his health and family. The Company’s Board of Directors has unanimously appointed Bradley L. Campbell, former...
09-22 04:06
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Canaccord Genuity Maintains Buy on Travere Therapeutics, Raises Price Target to $70
Canaccord Genuity analyst Edward Nash maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and raises the price target from $62 to $70.
08-07 07:08
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On
Travere Therapeutics Inc. (NASDAQ:TVTX) shares surged 13.44% to $63.55 in after-hours trading on Tuesday after the biopharmaceutical company posted second-quarter revenue that beat analyst expectations, even as earnings missed. Revenue Beat Drives Momentum For the period ended Jun. 30, Travere repor...
08-05 15:16
财报速睇 | Travere Therapeutics, Inc. 2026财年Q2营收1.70亿美元，同比增长48.2%；归母净利润亏损0.35亿美元，同比亏损扩大172.8%
华盛资讯8月5日讯，Travere Therapeutics, Inc.公布2026财年Q2业绩，公司Q2营收1.70亿美元，同比增长48.2%，归母净利润亏损0.35亿美元，同比亏损扩大172.8%。
08-05 04:28
